Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Sharp Biomedical closes pre-seed funding round to advance outpatient spine procedures, led by gener8tor, amount undisclosed.

PRIVATEOct 12, 2026

Round Type

Pre-Seed

FargoBiotechnologyHealth CareMedicalMedical Device

Investors

Gener8tor 1889

Description

Sharp Biomedical has successfully closed its pre-seed funding round led by gener8tor 1889, with participation from physician angel investors. The new capital will fund the development and testing of the company's first purpose-built toolset and implant system for outpatient clinics. This innovation aims to improve options for early-to-mid-stage chronic pain patients. The funding marks a significant step forward in addressing unmet needs earlier in the care continuum.

Company Information

Company

Sharp Biomedical

Location

Fargo, North Dakota, United States

About

Sharp Biomedical is a medical device company focused on creating novel, streamlined toolsets and implants for spinal care. By designing safe, manual procedures that can be performed in less operating time, Sharp Biomedical empowers outpatient pain clinics to treat early-to-mid-stage chronic pain, reducing the industry's reliance on large hospital infrastructure, robotics, and prolonged operating times.

Fundz sees it the moment Sharp Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Sharp Biomedical's next move

See what Strategic adds

Sharp Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.